Newsroom
Featured News
- Investors11 May 2022
Aztiq and Innobic officially become Lotus’s majority shareholders
- Investors16 May 2022
Lotus Reports Solid Performance in First Quarter of 2022
- Investors13 May 2022
Lotus hosts first quarter 2022 results investor conference
- Investors10 May 2022
Monthly sales report for April 2022
- Business14 April 2022
Lotus received approval for Alymsys®, a biosimilar to Avastin® (bevacizumab), in Taiwan
- Investors12 April 2022
Lotus attends Masterlink Securities investment conference
- Investors11 April 2022
Monthly sales report for March 2022
- Business22 March 2022
Lotus acquires Cialis® (Tadalafil) in Taiwan from Lilly
- Investors16 March 2022
Lotus attends President Securities investment conference
